FBGRX | FNILX | FBGRX / FNILX | |
Total Expense Ratio | 0.47 | 0.00 | - |
Annual Report Gross Expense Ratio | 0.47 | 0.00 | - |
Fund Existence | 38 years | 7 years | - |
Gain YTD | 5.106 | 7.600 | 67% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 76.5B | 13.6B | 563% |
Annual Yield % from dividends | 0.21 | 1.02 | 21% |
Returns for 1 year | 6.79 | 15.47 | 44% |
Returns for 3 years | 104.07 | 73.75 | 141% |
Returns for 5 years | 83.37 | 114.98 | 73% |
Returns for 10 years | 230.14 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
UBOT | 22.02 | 0.40 | +1.85% |
Direxion Dly Rbtc AI Atmtn Bl 2X ETF | |||
NBCR | 29.07 | 0.23 | +0.80% |
Neuberger Berman Core Equity ETF | |||
MSTB | 37.66 | 0.29 | +0.79% |
LHA Market State Tactical Beta ETF | |||
IBB | 130.00 | 0.45 | +0.35% |
iShares Biotechnology ETF | |||
GUG | 15.59 | -0.04 | -0.26% |
Guggenheim Active Allocation Fund |